GANZHOU ZHANGGONG KANGZHONG MEDICAL HEALTH INVESTMENT MANAGEMENT CO., LTD. has floated a tender for The First Phase Construction Project of the National Key Laboratory for Major Disease New Drug Target Discovery and New Drug Creation in Ganzhou City. The project location is China and the tender is closing on 14 May 2024. The tender notice number is -, while the TOT Ref Number is 100237695.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : China
Summary : The First Phase Construction Project of the National Key Laboratory for Major Disease New Drug Target Discovery and New Drug Creation in Ganzhou City